Team:KAIST Korea/Safety
From 2013.igem.org
(Difference between revisions)
(Prototype team page) |
|||
(3 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
- | <!-- | + | <!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> |
+ | <html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr"> | ||
+ | <head> | ||
+ | <meta http-equiv="Content-Type" content="text/html; charset=utf-8" /> | ||
+ | <meta name="generator" content="MediaWiki 1.16.5" /> | ||
+ | <link rel="alternate" type="application/x-wiki" title="Edit" href="/wiki/index.php?title=Team:KAIST_Korea/Safety&action=edit" /> | ||
+ | <link rel="edit" title="Edit" href="/wiki/index.php?title=Team:KAIST_Korea/Safety&action=edit" /> | ||
+ | <link rel="shortcut icon" href="/favicon.ico" /> | ||
+ | <link rel="search" type="application/opensearchdescription+xml" href="/wiki/opensearch_desc.php" title="2013.igem.org (en)" /> | ||
+ | <link title="Creative Commons" type="application/rdf+xml" href="/wiki/index.php?title=Team:KAIST_Korea/Safety&action=creativecommons" rel="meta" /> | ||
+ | <link rel="copyright" href="http://creativecommons.org/licenses/by/3.0/" /> | ||
+ | <meta name="viewport" content="width=device-width, initial-scale=1.0 minimum-scale=1, maximum-scale=1, user-scalable=yes, target-densitydpi=medium-dpi" /> | ||
+ | <link href='http://fonts.googleapis.com/css?family=Source+Sans+Pro:300,400,300italic' rel='stylesheet' type='text/css'> | ||
+ | <title>Team:KAIST Korea/Safety - 2013.igem.org</title> | ||
+ | <style type="text/css" media="screen, projection">/*<![CDATA[*/ | ||
+ | @import "/wiki/skins/common/shared.css?270"; | ||
+ | @import "/wiki/skins/igem/main.css?270"; | ||
- | < | + | #menu, |
- | < | + | #menu ul, |
- | < | + | #menu li, |
- | + | #menu a { | |
+ | margin: 0; | ||
+ | padding-left: 40; | ||
+ | border: none; | ||
+ | outline: none; | ||
+ | } | ||
+ | .menu { | ||
+ | height: 50px; | ||
+ | weight: 100%; | ||
+ | padding-left: 30%; | ||
+ | background: #4c4e5a; | ||
+ | } | ||
+ | |||
+ | .menu li { | ||
+ | position: relative; | ||
+ | list-style: none; | ||
+ | margin: 0px auto 0 auto; | ||
+ | float: left; | ||
+ | display: block; | ||
+ | height: 50px; | ||
+ | } | ||
+ | |||
+ | /* Links */ | ||
+ | |||
+ | .menu li a { | ||
+ | margin:0px auto; | ||
+ | display: block; | ||
+ | padding: 0 14px; | ||
+ | margin: 6px 0; | ||
+ | |||
+ | text-decoration: none; | ||
+ | |||
+ | |||
+ | |||
+ | font-family: Helvetica, Arial, sans-serif; | ||
+ | font-weight: bold; | ||
+ | font-size: 20px; | ||
+ | |||
+ | color: #353535; | ||
+ | |||
+ | |||
+ | -webkit-transition: color .2s ease-in-out; | ||
+ | -moz-transition: color .2s ease-in-out; | ||
+ | -o-transition: color .2s ease-in-out; | ||
+ | -ms-transition: color .2s ease-in-out; | ||
+ | transition: color .2s ease-in-out; | ||
+ | } | ||
+ | |||
+ | .menu li:first-child a { border-left: none; } | ||
+ | .menu li:last-child a{ border-right: none; } | ||
+ | |||
+ | .menu li:hover > a { color: #F29661; } | ||
+ | |||
+ | /* Sub Menu */ | ||
+ | |||
+ | .menu ul { | ||
+ | position: absolute; | ||
+ | top: 50px; | ||
+ | |||
+ | left: 0px; | ||
+ | |||
+ | padding-right: 10px; | ||
+ | |||
+ | opacity: 0; | ||
+ | |||
+ | background: #1f2024; | ||
+ | |||
+ | -webkit-border-radius: 0 0 5px 5px; | ||
+ | -moz-border-radius: 0 0 5px 5px; | ||
+ | border-radius: 0 0 5px 5px; | ||
+ | |||
+ | -webkit-transition: opacity .25s ease .1s; | ||
+ | -moz-transition: opacity .25s ease .1s; | ||
+ | -o-transition: opacity .25s ease .1s; | ||
+ | -ms-transition: opacity .25s ease .1s; | ||
+ | transition: opacity .25s ease .1s; | ||
+ | } | ||
+ | |||
+ | .menu li:hover > ul { opacity: 1; } | ||
+ | |||
+ | .menu ul li { | ||
+ | height: 0; | ||
+ | overflow: hidden; | ||
+ | padding: 0px; | ||
+ | |||
+ | -webkit-transition: height .25s ease .1s; | ||
+ | -moz-transition: height .25s ease .1s; | ||
+ | -o-transition: height .25s ease .1s; | ||
+ | -ms-transition: height .25s ease .1s; | ||
+ | transition: height .25s ease .1s; | ||
+ | } | ||
+ | |||
+ | .menu li:hover > ul li { | ||
+ | height: 40px; | ||
+ | overflow: visible; | ||
+ | padding: 0; | ||
+ | } | ||
+ | |||
+ | .menu ul li a { | ||
+ | width: 100px; | ||
+ | padding: 4px 0 4px 40px; | ||
+ | margin: 0; | ||
+ | |||
+ | border: none; | ||
+ | border-bottom: 1px solid #353539; | ||
+ | } | ||
+ | |||
+ | .menu ul li:last-child a { border: none; } | ||
+ | |||
+ | /* Icons */ | ||
+ | |||
+ | .menu a.documents { background: url(docs.png) no-repeat 6px center; } | ||
+ | .menu a.messages { background: url(bubble.png) no-repeat 6px center; } | ||
+ | .menu a.signout { background: url(arrow.png) no-repeat 6px center; } | ||
+ | |||
+ | |||
+ | ul.menu { margin: 0px auto 0 auto; } | ||
+ | </style> | ||
+ | |||
+ | <style type="text/css"> | ||
+ | |||
+ | /* Cross-Browsing */ | ||
+ | html,body,div,ul,ol,li,dl,dt,dd,h1,h2,h3,h4,h5,h6,pre,form,p,blockquote,fieldset,input,hr {margin:0; padding:0;} | ||
+ | h1,h2,h3,h4,h5,h6,pre,code,address,caption,cite,code,em,strong,th {font-size:1em; font-weight:normal; font-style:normal;} | ||
+ | ol, ul, li { list-style:none; } | ||
+ | fieldset,img,hr {border:none;} | ||
+ | caption,th {text-align:left;} | ||
+ | table {border-collapse:collapse; border-spacing:0;} | ||
+ | td {vertical-align:top;} | ||
+ | strong { font-weight:bold ;} | ||
+ | em { font-style:italic; } | ||
+ | a img { border:none; } | ||
+ | q:before, q:after { content:''} | ||
+ | |||
+ | html { height: 100%; } | ||
+ | |||
+ | |||
+ | body | ||
+ | { | ||
+ | background-image: url('https://static.igem.org/mediawiki/2012/6/61/Top_section_expand_KAIST.png'),url('https://static.igem.org/mediawiki/2012/9/98/PATTERN_diagonal.png'); | ||
+ | background-repeat: repeat-x,repeat; | ||
+ | margin: 0; | ||
+ | padding: 0; | ||
+ | } | ||
+ | |||
+ | |||
+ | |||
+ | #content | ||
+ | { | ||
+ | border: none; | ||
+ | position: relative; | ||
+ | top: 0; | ||
+ | background-color: transparent; | ||
+ | padding: 0; | ||
+ | width: 100%; | ||
+ | } | ||
+ | |||
+ | #bodyContent p | ||
+ | { | ||
+ | display: none; | ||
+ | } | ||
+ | |||
+ | #globalWrapper | ||
+ | { | ||
+ | clear: both; | ||
+ | width: 100%; | ||
+ | z-index: 1; | ||
+ | position: relative; | ||
+ | top:0px; | ||
+ | margin: auto; | ||
+ | font-size: 10px; | ||
+ | } | ||
+ | |||
+ | #contentSub { display: none; } | ||
+ | #siteSub { display:none; } | ||
+ | |||
+ | #search-controls { | ||
+ | left: 20px; | ||
+ | width: auto; | ||
+ | z-index: 100; | ||
+ | position: relative; | ||
+ | float: right; | ||
+ | top: -10px; | ||
+ | right: 0; | ||
+ | height: auto; | ||
+ | clear: both; | ||
+ | } | ||
+ | |||
+ | input.searchButton | ||
+ | { | ||
+ | position: relative; | ||
+ | font-size: 1em; | ||
+ | font-family: "Arial"; | ||
+ | font-weight: normal; | ||
+ | color: #FFFFFF; | ||
+ | } | ||
+ | |||
+ | #searchInput | ||
+ | { | ||
+ | background-color: transparent; | ||
+ | z-index: 100; | ||
+ | color: #181818; | ||
+ | font: Arial; | ||
+ | text-align: center; | ||
+ | |||
+ | background: url('https://static.igem.org/mediawiki/2012/6/6e/Kaist2012_head_searchbar.png') no-repeat; | ||
+ | background-position: 0px 0px; | ||
+ | vertical-align: middle; | ||
+ | |||
+ | width: 184px; | ||
+ | height: 22px; | ||
+ | border: none; | ||
+ | } | ||
+ | |||
+ | #searchGoButton | ||
+ | { | ||
+ | font-size: 0pt; | ||
+ | background: url('https://static.igem.org/mediawiki/2012/7/78/Kaist2012_head_arrow.png') no-repeat; | ||
+ | background-position: left 0px; | ||
+ | z-index: 100; | ||
+ | cursor: pointer; | ||
+ | width: 29px; | ||
+ | height: 29px; | ||
+ | border: none; | ||
+ | } | ||
+ | |||
+ | #mw-searchButton | ||
+ | { | ||
+ | position: relative; | ||
+ | left: -14px; | ||
+ | font-size: 0pt; | ||
+ | background: url('https://static.igem.org/mediawiki/2012/e/e1/Kaist2012_head_search.png') no-repeat; | ||
+ | z-index: 100; | ||
+ | background-position: left 0px; | ||
+ | cursor: pointer; | ||
+ | width: 29px; | ||
+ | height: 29px; | ||
+ | border: none; | ||
+ | } | ||
+ | |||
+ | .firstHeading { display:none; } | ||
+ | |||
+ | #p-logo | ||
+ | { | ||
+ | display: none; | ||
+ | position: relative; | ||
+ | top: 0px; | ||
+ | z-index: 0; | ||
+ | height: 1px; | ||
+ | width: 10px; | ||
+ | overflow: hidden; | ||
+ | } | ||
+ | |||
+ | #p-logo a { color: black; } | ||
+ | |||
+ | img[src*="/wiki/skins/common/images/wiki.png"] | ||
+ | { | ||
+ | visibility: hidden; | ||
+ | top: -100px; | ||
+ | width: 10px; | ||
+ | height: 0px; | ||
+ | margin-top: 20px; | ||
+ | background: transparent; | ||
+ | } | ||
+ | |||
+ | |||
+ | |||
+ | #menubar | ||
+ | { | ||
+ | font-size: 10px; | ||
+ | font-family: "GothamXNarrow-Bold", "Helvetica"; | ||
+ | position: relative; | ||
+ | float: left; | ||
+ | width: auto; | ||
+ | top: 36px; | ||
+ | z-index: 100; | ||
+ | } | ||
+ | |||
+ | #menubar:hover{ background-color: #181818; } | ||
+ | |||
+ | .left-menu { margin-top: 0px; left: 0; } | ||
+ | .left-menu ul { border: none;} | ||
+ | .right-menu { margin-top: 0px; right: 0; float: right !important;} | ||
+ | .right-menu ul { border: none; } | ||
+ | .right-menu ul a { background-color: transparent; } | ||
+ | .left-menu li a { color: #615d5a; } | ||
+ | .left-menu li a:visited { color: #615d5a; } | ||
+ | .left-menu li a:hover { color: #ffffff; } | ||
+ | .left-menu li a:active{ color: #cccccc; font-weight: bold; } | ||
+ | .right-menu li a { color: #f6f5c8; } | ||
+ | .right-menu li a:visited { color: #f6f5c8; } | ||
+ | .right-menu li a:hover { color: #ffffff; text-decoration: none; } | ||
+ | .right-menu li a:active { color: #cccccc; text-decoration: none;font-weight: bold; } | ||
+ | |||
+ | #menubar li { | ||
+ | |||
+ | margin: 0px; | ||
+ | word-spacing:-1px; | ||
+ | } | ||
+ | |||
+ | #catlinks { | ||
+ | position: relative; | ||
+ | top: 5px; | ||
+ | left: -5px; | ||
+ | width: 1034px; | ||
+ | border: none; | ||
+ | background-color: transparent; | ||
+ | padding-top: 5px; | ||
+ | clear: both; | ||
+ | } | ||
+ | |||
+ | #footer-box {display:none;} | ||
+ | #footer {display:none;} | ||
+ | #footer li a { color: #000000; } | ||
+ | #footer img { margin: 10px; border: none; } | ||
+ | #footer li a:visited {color: #000000;} | ||
+ | #footer li a:hover { color: #ababab; text-decoration: none; } | ||
+ | #footer li a:active{ color: #ababab; text-decoration: none; font-weight: bold} | ||
+ | </style> | ||
+ | <style> | ||
+ | @import url(http://fonts.googleapis.com/css?family=Source+Sans+Pro:300,400,300italic); | ||
+ | ul.oe_menu{ | ||
+ | list-style:none; | ||
+ | position:relative; | ||
+ | width:300px; | ||
+ | float:left; | ||
+ | clear:both; | ||
+ | margin:5px 0px 0px 8px; | ||
+ | } | ||
+ | ul.oe_menu > li{ | ||
+ | width:90px; | ||
+ | height:30px; | ||
+ | padding:auto; | ||
+ | float:left; | ||
+ | position:relative; | ||
+ | list-style-type:none; | ||
+ | |||
+ | } | ||
+ | |||
+ | ul.oe_menu > li > a{ | ||
+ | display:block; | ||
+ | background-color:transparent; | ||
+ | color:#aaa; | ||
+ | text-decoration:none; | ||
+ | text-align:center; | ||
+ | font-size:16px; | ||
+ | font-family: 'Source Sans Pro', sans-serif; | ||
+ | width:90px; | ||
+ | height:30px; | ||
+ | opacity:0.8; | ||
+ | } | ||
+ | ul.oe_menu > li > a:hover, | ||
+ | ul.oe_menu > li.selected > a{ | ||
+ | color:#fff; | ||
+ | opacity:1.0; | ||
+ | } | ||
+ | .oe_wrapper ul.hovered > li > a{ | ||
+ | background:transparent; | ||
+ | |||
+ | } | ||
+ | ul.oe_menu div{ | ||
+ | position:absolute; | ||
+ | left:0px; | ||
+ | background:transparent; | ||
+ | width:268px; | ||
+ | height:36px; | ||
+ | padding:2px; | ||
+ | display:none; | ||
+ | } | ||
+ | ul.oe_menu div ul li a{ | ||
+ | text-decoration:none; | ||
+ | color:#cbcbcb; | ||
+ | padding:2px 2px 2px 4px; | ||
+ | display:block; | ||
+ | font-family: 'Source Sans Pro', sans-serif; | ||
+ | text-align:center; | ||
+ | font-size:16px; | ||
+ | } | ||
+ | ul.oe_menu div ul.oe_full{ | ||
+ | width:100%; | ||
+ | } | ||
+ | ul.oe_menu div ul li a:hover{ | ||
+ | background:#8583bf;/*이걸로 색상 조절*/ | ||
+ | color:#fff; | ||
+ | } | ||
+ | ul.oe_menu li ul{ | ||
+ | list-style:none; | ||
+ | float:left; | ||
+ | width: 86px; | ||
+ | margin-right:0px; | ||
+ | } | ||
+ | |||
+ | ul.oe_menu2{ | ||
+ | list-style:none; | ||
+ | position:relative; | ||
+ | width:300px; | ||
+ | float:left; | ||
+ | clear:both; | ||
+ | margin:5px 0px 0px 8px; | ||
+ | } | ||
+ | ul.oe_menu2 > li{ | ||
+ | width:90px; | ||
+ | height:30px; | ||
+ | padding:auto; | ||
+ | float:left; | ||
+ | position:relative; | ||
+ | list-style-type:none; | ||
+ | } | ||
+ | |||
+ | ul.oe_menu2 > li > a{ | ||
+ | display:block; | ||
+ | background-color:transparent; | ||
+ | color:#eee; | ||
+ | text-decoration:none; | ||
+ | text-align:center; | ||
+ | font-size:16px; | ||
+ | font-family: 'Source Sans Pro', sans-serif; | ||
+ | width:90px; | ||
+ | height:30px; | ||
+ | opacity:0.8; | ||
+ | } | ||
+ | ul.oe_menu2 > li > a:hover, | ||
+ | ul.oe_menu2 > li.selected > a{ | ||
+ | color:#fff; | ||
+ | opacity:1.0; | ||
+ | } | ||
+ | |||
+ | .oe_wrapper2 ul.hovered > li > a{ | ||
+ | background:transparent; | ||
+ | |||
+ | } | ||
+ | |||
+ | ul.oe_menu2 div{ | ||
+ | position:absolute; | ||
+ | left:0px; | ||
+ | background:transparent; | ||
+ | width:268px; | ||
+ | height:36px; | ||
+ | padding:2px; | ||
+ | display:none; | ||
+ | } | ||
+ | ul.oe_menu2 div ul li a{ | ||
+ | text-decoration:none; | ||
+ | color:#ffffff; | ||
+ | padding:2px 2px 2px 2px; | ||
+ | display:block; | ||
+ | font-family: 'Source Sans Pro', sans-serif; | ||
+ | text-align:center; | ||
+ | font-size:16px; | ||
+ | } | ||
+ | |||
+ | ul.oe_menu2 div ul.oe_full2{ | ||
+ | width:100%; | ||
+ | } | ||
+ | |||
+ | ul.oe_menu2 div ul li a:hover{ | ||
+ | background:#d37c62;/*이걸로 색상 조절*/ | ||
+ | color:#fff; | ||
+ | } | ||
+ | |||
+ | ul.oe_menu2 li ul{ | ||
+ | list-style:none; | ||
+ | float:left; | ||
+ | width: 86px; | ||
+ | margin-right:0px; | ||
+ | } | ||
+ | |||
+ | #main | ||
+ | { | ||
+ | min-height: 100%; | ||
+ | width: 1024px; | ||
+ | margin: 0 auto; | ||
+ | background-color: transparent; | ||
+ | background-image:url("https://static.igem.org/mediawiki/2012/d/da/Kaist_home_background_y_extended.png"); | ||
+ | background-repeat:repeat-y; | ||
+ | } | ||
+ | |||
+ | #main #main-img | ||
+ | { | ||
+ | position: absolute; | ||
+ | width: 1024px; | ||
+ | top: -30px; | ||
+ | z-index:0; | ||
+ | } | ||
+ | |||
+ | #main a #main-logo | ||
+ | { | ||
+ | position: absolute; | ||
+ | top: -30px; | ||
+ | width: 336px; | ||
+ | z-index:1; | ||
+ | } | ||
+ | |||
+ | #main #top-img | ||
+ | { | ||
+ | position: relative; | ||
+ | top: -5px; | ||
+ | left:292px; | ||
+ | width:732px; | ||
+ | height: 250px; | ||
+ | z-index: 0; | ||
+ | opacity:0.9; | ||
+ | } | ||
+ | |||
+ | div .oe_wrapper{ | ||
+ | position:absolute; | ||
+ | z-index:3; | ||
+ | top:275px; | ||
+ | } | ||
+ | |||
+ | div .oe_wrapper2{ | ||
+ | position:absolute; | ||
+ | z-index:2; | ||
+ | top:358px; | ||
+ | } | ||
+ | |||
+ | div .iGEMLogo{ | ||
+ | position:absolute; | ||
+ | z-index:4; | ||
+ | bottom: 80px; | ||
+ | padding : 0 0 0 10px; | ||
+ | } | ||
+ | |||
+ | #menucontent | ||
+ | { | ||
+ | position: relative; | ||
+ | background-color:transparent; | ||
+ | width:690px; | ||
+ | left:320px; | ||
+ | top:-75px; | ||
+ | z-index:2; | ||
+ | text-align: right; | ||
+ | opacity:0.8; | ||
+ | } | ||
+ | |||
+ | #top-img-description | ||
+ | { | ||
+ | font-size:25px; | ||
+ | font-family: 'Gloria Hallelujah', cursive; | ||
+ | } | ||
+ | |||
+ | #top-img-description-box | ||
+ | { | ||
+ | position: relative; | ||
+ | background-color:transparent; | ||
+ | top:-115px; | ||
+ | left: 350px; | ||
+ | z-index:3; | ||
+ | height:15px; | ||
+ | } | ||
+ | |||
+ | #horizontal-line | ||
+ | { | ||
+ | position: relative; | ||
+ | background-color:transparent; | ||
+ | width:732px; | ||
+ | height:3px; | ||
+ | left:292px; | ||
+ | top:-90px; | ||
+ | z-index:2; | ||
+ | } | ||
+ | div .contact-us{ | ||
+ | position: absolute; | ||
+ | z-index:2; | ||
+ | top:450px; | ||
+ | padding:4px 0px 0px 10px; | ||
+ | width:268px; | ||
+ | color:white; | ||
+ | font-weight:bold; | ||
+ | } | ||
+ | |||
+ | div .contact-us #contact-us-information{ | ||
+ | font-family: 'Source Sans Pro', sans-serif; | ||
+ | font-size:12px; | ||
+ | font-style: italic; | ||
+ | color:white; | ||
+ | } | ||
+ | |||
+ | div .contact-us #contact-us-information a:hover{ | ||
+ | font-family: 'Source Sans Pro', sans-serif; | ||
+ | font-size:12px; | ||
+ | font-style: italic; | ||
+ | color:#fcf967; | ||
+ | font-weight:bold; | ||
+ | text-decoration:none; | ||
+ | } | ||
+ | |||
+ | div .contact-us #contact-us-information a{ | ||
+ | font-family: 'Source Sans Pro', sans-serif; | ||
+ | font-size:12px; | ||
+ | font-style: italic; | ||
+ | color:white; | ||
+ | text-decoration:none; | ||
+ | } | ||
+ | |||
+ | div .contact-us #contact-us-title{ | ||
+ | font-family: 'Source Sans Pro', sans-serif; | ||
+ | font-size:22px; | ||
+ | line-height:170%; | ||
+ | color:#dddddd; | ||
+ | height:30px; | ||
+ | } | ||
+ | |||
+ | </style> | ||
+ | <script type="text/javascript"> | ||
+ | WebFontConfig = { | ||
+ | google: { families: [ 'Source+Sans+Pro:300,400,300italic:latin' ] } | ||
+ | }; | ||
+ | (function() { | ||
+ | var wf = document.createElement('script'); | ||
+ | wf.src = ('https:' == document.location.protocol ? 'https' : 'http') + | ||
+ | '://ajax.googleapis.com/ajax/libs/webfont/1/webfont.js'; | ||
+ | wf.type = 'text/javascript'; | ||
+ | wf.async = 'true'; | ||
+ | var s = document.getElementsByTagName('script')[0]; | ||
+ | s.parentNode.insertBefore(wf, s); | ||
+ | })(); </script> | ||
+ | <link rel="stylesheet" type="text/css" media="print" href="/wiki/skins/common/commonPrint.css?270" /> | ||
+ | <meta http-equiv="imagetoolbar" content="no" /> | ||
+ | <script> | ||
+ | var skin="igem", | ||
+ | stylepath="/wiki/skins", | ||
+ | wgUrlProtocols="http\\:\\/\\/|https\\:\\/\\/|ftp\\:\\/\\/|irc\\:\\/\\/|gopher\\:\\/\\/|telnet\\:\\/\\/|nntp\\:\\/\\/|worldwind\\:\\/\\/|mailto\\:|news\\:|svn\\:\\/\\/", | ||
+ | wgArticlePath="/$1", | ||
+ | wgScriptPath="/wiki", | ||
+ | wgScriptExtension=".php", | ||
+ | wgScript="/wiki/index.php", | ||
+ | wgVariantArticlePath=false, | ||
+ | wgActionPaths={}, | ||
+ | wgServer="https://2013.igem.org", | ||
+ | wgCanonicalNamespace="", | ||
+ | wgCanonicalSpecialPageName=false, | ||
+ | wgNamespaceNumber=0, | ||
+ | wgPageName="Team:KAIST_Korea/Safety", | ||
+ | wgTitle="Team:KAIST Korea/Safety", | ||
+ | wgAction="view", | ||
+ | wgArticleId=9665, | ||
+ | wgIsArticle=true, | ||
+ | wgUserName="Springkjw", | ||
+ | wgUserGroups=["*", "user", "autoconfirmed"], | ||
+ | wgUserLanguage="en", | ||
+ | wgContentLanguage="en", | ||
+ | wgBreakFrames=false, | ||
+ | wgCurRevisionId=297918, | ||
+ | wgVersion="1.16.0", | ||
+ | wgEnableAPI=true, | ||
+ | wgEnableWriteAPI=true, | ||
+ | wgSeparatorTransformTable=["", ""], | ||
+ | wgDigitTransformTable=["", ""], | ||
+ | wgMainPageTitle="Main Page", | ||
+ | wgFormattedNamespaces={"-2": "Media", "-1": "Special", "0": "", "1": "Talk", "2": "User", "3": "User talk", "4": "2013.igem.org", "5": "2013.igem.org talk", "6": "File", "7": "File talk", "8": "MediaWiki", "9": "MediaWiki talk", "10": "Template", "11": "Template talk", "12": "Help", "13": "Help talk", "14": "Category", "15": "Category talk"}, | ||
+ | wgNamespaceIds={"media": -2, "special": -1, "": 0, "talk": 1, "user": 2, "user_talk": 3, "2013.igem.org": 4, "2013.igem.org_talk": 5, "file": 6, "file_talk": 7, "mediawiki": 8, "mediawiki_talk": 9, "template": 10, "template_talk": 11, "help": 12, "help_talk": 13, "category": 14, "category_talk": 15, "image": 6, "image_talk": 7}, | ||
+ | wgSiteName="2013.igem.org", | ||
+ | wgCategories=[], | ||
+ | wgMWSuggestTemplate="https://2013.igem.org/wiki/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest", | ||
+ | wgDBname="2013_igem_org", | ||
+ | wgSearchNamespaces=[0], | ||
+ | wgMWSuggestMessages=["with suggestions", "no suggestions"], | ||
+ | wgRestrictionEdit=[], | ||
+ | wgRestrictionMove=[], | ||
+ | wgAjaxWatch={"watchMsg": "Watch", "unwatchMsg": "Unwatch", "watchingMsg": "Watching...", "unwatchingMsg": "Unwatching...", "tooltip-ca-watchMsg": "Add this page to your watchlist", "tooltip-ca-unwatchMsg": "Remove this page from your watchlist"}; | ||
+ | </script> | ||
+ | <script type="text/javascript" src="/wiki/skins/common/wikibits.js?270"><!-- wikibits js --></script> | ||
+ | <!-- Head Scripts --> | ||
+ | <script src="/wiki/skins/common/ajax.js?270"></script> | ||
+ | <script src="/wiki/skins/common/ajaxwatch.js?270"></script> | ||
+ | <script src="/wiki/skins/common/mwsuggest.js?270"></script> | ||
+ | <script type="text/javascript" src="/wiki/index.php?title=-&action=raw&smaxage=0&gen=js&useskin=igem"><!-- site js --></script> | ||
+ | <!-- jQuery Javascript --> | ||
+ | <script type='text/javascript' src ='/common/jquery-latest.min.js'></script> | ||
+ | <script type='text/javascript' src ='/common/tablesorter/jquery.tablesorter.min.js'></script> | ||
+ | <link rel='stylesheet' type='text/css' href='/common/tablesorter/themes/groupparts/style.css' /> | ||
+ | <link rel='stylesheet' type='text/css' href='/common/table_styles.css' /> | ||
+ | <link rel='stylesheet' type='text/css' href='/forum/forum_styles.css' /> | ||
+ | <script type='text/javascript' src ='/forum/forum_scripts.js'></script> | ||
+ | |||
+ | |||
+ | <link href='http://fonts.googleapis.com/css?family=Gloria+Hallelujah|Open+Sans:600italic,400,800' rel='stylesheet' type='text/css'> | ||
+ | <script type="text/javascript"> | ||
+ | WebFontConfig = { | ||
+ | google: { families: [ 'Open+Sans:600italic,400,800:latin' ]|[ 'Gloria+Hallelujah::latin' ]} | ||
+ | }; | ||
+ | (function() { | ||
+ | var wf = document.createElement('script'); | ||
+ | wf.src = ('https:' == document.location.protocol ? 'https' : 'http') + | ||
+ | '://ajax.googleapis.com/ajax/libs/webfont/1/webfont.js'; | ||
+ | wf.type = 'text/javascript'; | ||
+ | wf.async = 'true'; | ||
+ | var s = document.getElementsByTagName('script')[0]; | ||
+ | s.parentNode.insertBefore(wf, s); | ||
+ | })(); | ||
+ | </script> | ||
+ | <style> | ||
+ | @import url(http://fonts.googleapis.com/css?family=Gloria+Hallelujah|Open+Sans:600italic,400,800); | ||
+ | |||
+ | #kaistcontent | ||
+ | { | ||
+ | position: relative; | ||
+ | background-color:transparent; | ||
+ | width:690px; | ||
+ | font-family: 'Open Sans', sans-serif; | ||
+ | font-size:11pt; | ||
+ | line-height:140%; | ||
+ | padding: 0px 15px 0px 15px; | ||
+ | left:300px; | ||
+ | top:-70px; | ||
+ | z-index: 2; | ||
+ | } | ||
+ | |||
+ | #kaistcontent #tab | ||
+ | { | ||
+ | width:200px; | ||
+ | height:30px; | ||
+ | position:relative; | ||
+ | background:#f2f3f3; | ||
+ | padding:5px 30px 5px 30px; | ||
+ | border:1px solid #f4f4f4; | ||
+ | margin : 0 20px 0 20px; | ||
+ | } | ||
+ | |||
+ | |||
+ | |||
+ | #kaistcontent #starter-grad | ||
+ | { | ||
+ | width:17px; | ||
+ | height:100px; | ||
+ | float:left; | ||
+ | margin:0px 15px 2px 0px; | ||
+ | } | ||
+ | |||
+ | #kaistcontent #starter | ||
+ | { | ||
+ | font-family: 'Open Sans', sans-serif; | ||
+ | font-size:25pt; | ||
+ | color: #08185d; | ||
+ | font-style:italic | ||
+ | padding:0px 0px 0px 10px; | ||
+ | } | ||
+ | |||
+ | #kaistcontent #sub-title | ||
+ | { | ||
+ | font-family: 'Open Sans', sans-serif; | ||
+ | color:#848383; | ||
+ | font-size: 15pt; | ||
+ | line-height:100%; | ||
+ | font-weight:bold; | ||
+ | font-style:italic; | ||
+ | } | ||
+ | |||
+ | #kaistcontent h1 | ||
+ | { | ||
+ | font-family: 'Open Sans', sans-serif; | ||
+ | color:#5c5858; | ||
+ | font-weight:bold; | ||
+ | font-size:24pt; | ||
+ | line-height:110%; | ||
+ | } | ||
+ | |||
+ | #kaistcontent ul | ||
+ | { | ||
+ | list-style-type:disc; | ||
+ | padding: 0px 0px 0px 30px; | ||
+ | |||
+ | } | ||
+ | |||
+ | #kaistcontent li | ||
+ | { | ||
+ | list-style-type:decimal; | ||
+ | } | ||
+ | |||
+ | #kaistcontent a { | ||
+ | color:#5a5b5e; | ||
+ | } | ||
+ | |||
+ | #kaistcontent a:hover{ | ||
+ | color:#94969a; | ||
+ | } | ||
+ | |||
+ | |||
+ | #kaistcontent #little | ||
+ | { | ||
+ | padding: 0px 0px 0px 30px; | ||
+ | line-height:140%; | ||
+ | } | ||
+ | #kaistcontent #little2 | ||
+ | { | ||
+ | padding: 0px 0px 0px 15px; | ||
+ | line-height:140%; | ||
+ | } | ||
+ | |||
+ | #kaistcontent #sub-sub-title | ||
+ | { | ||
+ | font-family: 'Open Sans', sans-serif; | ||
+ | color:#848383; | ||
+ | font-weight:bold; | ||
+ | font-size:14pt; | ||
+ | line-height:110%; | ||
+ | } | ||
+ | |||
+ | </style> | ||
+ | <script type="text/javascript" src="http://ajax.googleapis.com/ajax/libs/jquery/1.4.3/jquery.min.js"></script> | ||
+ | <script type="text/javascript"> | ||
+ | $(function() { | ||
+ | var $oe_menu = $('#oe_menu'); | ||
+ | var $oe_menu_items = $oe_menu.children('li'); | ||
+ | |||
+ | $oe_menu_items.bind('mouseenter',function(){ | ||
+ | var $this = $(this); | ||
+ | $this.addClass('slided selected'); | ||
+ | $this.children('div').css('z-index','9999').stop(true,true).slideDown(200,function(){ | ||
+ | $oe_menu_items.not('.slided').children('div').hide(); | ||
+ | $this.removeClass('slided'); | ||
+ | }); | ||
+ | }).bind('mouseleave',function(){ | ||
+ | var $this = $(this); | ||
+ | $this.removeClass('selected').children('div').css('z-index','1'); | ||
+ | }); | ||
+ | |||
+ | $oe_menu.bind('mouseenter',function(){ | ||
+ | var $this = $(this); | ||
+ | $this.addClass('hovered'); | ||
+ | }).bind('mouseleave',function(){ | ||
+ | var $this = $(this); | ||
+ | $this.removeClass('hovered'); | ||
+ | $oe_menu_items.children('div').hide(); | ||
+ | }) | ||
+ | }); | ||
+ | </script> | ||
+ | <script type="text/javascript"> | ||
+ | |||
+ | $(function() { | ||
+ | var $oe_menu2 = $('#oe_menu2'); | ||
+ | var $oe_menu_items2 = $oe_menu2.children('li'); | ||
+ | |||
+ | $oe_menu_items2.bind('mouseenter',function(){ | ||
+ | var $this = $(this); | ||
+ | $this.addClass('slided selected'); | ||
+ | $this.children('div').css('z-index','9999').stop(true,true).slideDown(200,function(){ | ||
+ | $oe_menu_items2.not('.slided').children('div').hide(); | ||
+ | $this.removeClass('slided'); | ||
+ | }); | ||
+ | }).bind('mouseleave',function(){ | ||
+ | var $this = $(this); | ||
+ | $this.removeClass('selected').children('div').css('z-index','1'); | ||
+ | }); | ||
+ | |||
+ | $oe_menu2.bind('mouseenter',function(){ | ||
+ | var $this = $(this); | ||
+ | $this.addClass('hovered'); | ||
+ | }).bind('mouseleave',function(){ | ||
+ | var $this = $(this); | ||
+ | $this.removeClass('hovered'); | ||
+ | $oe_menu_items2.children('div').hide(); | ||
+ | }) | ||
+ | }); | ||
+ | </script> | ||
+ | |||
+ | |||
+ | <style> | ||
+ | #kaist-footerbox | ||
+ | { | ||
+ | position: relative; | ||
+ | background-color: transparent; | ||
+ | width:1024px; | ||
+ | height:56px; | ||
+ | z-index:2; | ||
+ | margin:0 auto; | ||
+ | bottom:30px; | ||
+ | } | ||
+ | |||
+ | #kaist-footerbox img #footer-img | ||
+ | { | ||
+ | position: center; | ||
+ | width: 1024px; | ||
+ | height:106px; | ||
+ | z-index:2; | ||
+ | opacity:0.9; | ||
+ | margin:0 auto; | ||
+ | } | ||
+ | |||
+ | |||
+ | </style> | ||
+ | </head> | ||
+ | <body> | ||
+ | <div id="main"> | ||
+ | |||
+ | |||
+ | <a href="https://2013.igem.org/Team:KAIST_Korea"><img id="main-logo" src="https://static.igem.org/mediawiki/2013/5/59/Logopart_Kaist.png"/></a> | ||
+ | <img id="main-img" src="https://static.igem.org/mediawiki/2012/6/61/Home_kaist_background.png"/> | ||
+ | |||
+ | |||
+ | <ul class="menu"> | ||
+ | <li><a href="https://2013.igem.org/Team:KAIST_Korea">Home</a></li> | ||
+ | <li><a href="https://2013.igem.org/Team:KAIST_Korea/Team">Team</a></li> | ||
+ | <li><a href="https://2013.igem.org/Team:KAIST_Korea/Project">Project</a> | ||
+ | |||
+ | <!-- <ul> | ||
+ | <li><a href="#" class="documents">Documents</a></li> | ||
+ | <li><a href="#" class="messages">Messages</a></li> | ||
+ | <li><a href="#" class="signout">Sign Out</a></li> | ||
+ | </ul> | ||
+ | |||
+ | --> | ||
+ | |||
+ | </li> | ||
+ | <li><a href="#">Labnote</a></li> | ||
+ | <li><a href="#">Human Practice</a></li> | ||
+ | <li><a href="https://2013.igem.org/Team:KAIST_Korea/Safety">Safety</a></li> | ||
+ | |||
+ | </ul> <!-- end .menu --> | ||
+ | |||
+ | |||
+ | <div class="oe_wrapper"> | ||
+ | <ul id="oe_menu" class="oe_menu"> | ||
+ | <li><a href="https://2012.igem.org/Team:KAIST_Korea/Home_Intro">HOME</a> | ||
+ | <div style="top:30px;"> | ||
+ | <ul style="margin:0 0 0 30px;width:100px;"> | ||
+ | <li><a href="https://2012.igem.org/Team:KAIST_Korea/Home_Intro">Introduction</a></li> | ||
+ | </ul> | ||
+ | <ul style="width:100px;margin:0px 5px 0px 5px;"> | ||
+ | <li style="font-size:14px;"><a href="https://2012.igem.org/Team:KAIST_Korea/Home_iGEM">iGEM</a></li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | </li> | ||
+ | <li><a href="https://2012.igem.org/Team:KAIST_Korea/Team_Members">TEAM</a> | ||
+ | <div style="left:-85px;top:25px;"><!-- -112px --> | ||
+ | <ul> | ||
+ | <li><a style="font-size:14px;"href="https://igem.org/Team.cgi?id=907">Official Team Profile</a></li> | ||
+ | </ul> | ||
+ | <ul style="padding:5px 0px 5px 0px"> | ||
+ | <li><a href="https://2012.igem.org/Team:KAIST_Korea/Team_KAIST">Members</a></li> | ||
+ | </ul> | ||
+ | <ul style="padding:5px 0px 5px 0px"> | ||
+ | <li><a href="https://2012.igem.org/Team:KAIST_Korea/Team_Gallery">Gallery</a></li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | </li> | ||
+ | <li><a href="https://2012.igem.org/Team:KAIST_Korea/Part_About">DATA</a> | ||
+ | <div style="left:-182px;top:30px;"> | ||
+ | <ul style="margin:0 0 0 30px;width:100px;"> | ||
+ | <li><a href="https://2012.igem.org/Team:KAIST_Korea/Part_About">Description</a></li> | ||
+ | </ul> | ||
+ | <ul style="width:100px"> | ||
+ | <li><a href="https://2012.igem.org/Team:KAIST_Korea/Part_Bio">Bio Bricks</a></li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | </li> | ||
+ | |||
+ | </ul> | ||
+ | </div> | ||
+ | <div class="oe_wrapper2"> | ||
+ | <ul id="oe_menu2" class="oe_menu2"> | ||
+ | <li><a href="https://2013.igem.org/Team:KAIST_Korea/Project">PROJECT</a> | ||
+ | <div style="top:21px;left:32px;"> | ||
+ | <ul style="width:100px;height:19px;"> | ||
+ | <li><a style="font-size:14px;" href="https://2012.igem.org/Team:KAIST_Korea/Project_Background">Overview</a></li> | ||
+ | </ul> | ||
+ | <ul style="width:100px;height:19px;"> | ||
+ | <li><a style="font-size:14px;" href="https://2012.igem.org/Team:KAIST_Korea/Project_Results">Results</a></li> | ||
+ | </ul> | ||
+ | <ul style="width:100px;height:19px;"> | ||
+ | <li><a style="font-size:14px;" href="https://2012.igem.org/Team:KAIST_Korea/Project_Future">Future Plan</a></li> | ||
+ | </ul> | ||
+ | <ul style="width:100px;height:19px;"> | ||
+ | <li><a style="font-size:14px;" href="https://2012.igem.org/Team:KAIST_Korea/Project_Modeling">Modeling</a></li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | </li> | ||
+ | <li><a href="https://2012.igem.org/Team:KAIST_Korea/Notebook_Labnote">NOTEBOOK</a> | ||
+ | <div style="left:-91px;top:30px;"><!-- -112px --> | ||
+ | <ul style="margin:0 0 0 30px;width:100px;"> | ||
+ | <li><a href="https://2012.igem.org/Team:KAIST_Korea/Notebook_Labnote">Labnote</a></li> | ||
+ | </ul> | ||
+ | <ul style="width:100px"> | ||
+ | <li><a href="https://2012.igem.org/Team:KAIST_Korea/Notebook_Protocol">Protocol</a></li> | ||
+ | </ul> | ||
+ | |||
+ | </div> | ||
+ | </li> | ||
+ | <li><a href="https://2012.igem.org/Team:KAIST_Korea/Plus_Safety">PLUS</a> | ||
+ | <div style="left:-152px;top:21px;"> | ||
+ | <ul style="width:100px;height:19px;"> | ||
+ | <li><a style="font-size:14px;" href="https://2012.igem.org/Team:KAIST_Korea/Plus_Safety">Safety</a></li> | ||
+ | </ul> | ||
+ | <ul style="width:100px;height:19px;"> | ||
+ | <li><a style="font-size:14px;" href="https://2012.igem.org/Team:KAIST_Korea/Plus_Human">Human Practice</a></li> | ||
+ | </ul> | ||
+ | <ul style="width:100px;height:19px;"> | ||
+ | <li><a style="font-size:14px;" href="https://2012.igem.org/Team:KAIST_Korea/Plus_Attribution">Attribution</a></li> | ||
+ | </ul> | ||
+ | <ul style="width:100px;height:19px;"> | ||
+ | <li><a style="font-size:14px;" href="https://2012.igem.org/Team:KAIST_Korea/Plus_Sponsor">Sponsors</a></li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | </li> | ||
+ | |||
+ | </ul> | ||
+ | </div> | ||
+ | <div class="contact-us"> | ||
+ | <div id="contact-us-title">2013 KAIST Korea</div> | ||
+ | <div id="contact-us-information"> | ||
+ | <b>Mail</b> : <a href="mailto:kaist.igem.2012@gmail.com">kaist.igem.2012@gmail.com</a></br> | ||
+ | <b>Twitter</b> : <a href="http://twitter.com/KAIST_iGEM_2012">twitter.com/KAIST_iGEM_2012</a></br> | ||
+ | <b>Facebook</b> : <a href="http://www.facebook.com/KAISTiGEM2012">www.facebook.com/KAISTiGEM2012</a> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div class="iGEMLogo"> | ||
+ | <a href="https://igem.org/Main_Page"><img src="https://static.igem.org/mediawiki/2012/0/00/KAIST_iGEM_logo.png"/></a> | ||
</div> | </div> | ||
- | |||
- | |||
</div> | </div> | ||
- | <div id=" | + | <div id="main"> |
- | + | <img id="top-img" src="https://static.igem.org/mediawiki/2012/6/6d/Back_home.PNG"/> | |
- | < | + | |
- | < | + | |
- | </ | + | |
+ | <div id="kaistcontent"> | ||
+ | <div> | ||
+ | <img id="starter-grad" style="height:60px" src="https://static.igem.org/mediawiki/2012/9/95/Starter_gradient_kaist.png"></img> | ||
- | < | + | <h1>Safety</h1> |
+ | </br></br></br> | ||
+ | <span id="sub-sub-title"> 1. Would any of your project ideas raise safety issues in terms of: </span></br></br> | ||
- | + | <ul> | |
- | + | <li><span id="sub-title">Researcher</span></li></br> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
+ | <span id="little"> | ||
+ | For researcher safety, KAIST iGEM 2012 team follows rules of KAIST biology labs. Every researcher of our team wears latex gloves and lab coats in the lab which are sterilized frequently by spraying 70% ethanol. When treating toxic and volatile reagents, such as TEMED (the reagent used in SDS gel), we use chemical hood. Among several toxic reagents, potential carcinogens are those that are treated most carefully. To minimize the use of carcinogen, we do not use Ethidium Bromide (EtBr) in gel electrophoresis. Rather, we use RedSafeTM nucleic acid staining solution (CHEMBIO) to stain DNA samples when running gel electrophoresis. Since this reagent is said to be non-toxic, non-mutagenic, and non-carcinogenic, we believe using this reagent when making agarose gel would lessen the threat to researchers as well as to the environment. In addition, acrylamide, a component of SDS gel, is known as a potent neurotoxin hence we always wear latex gloves when preparing and running SDS PAGE. Plus, every month, every lab, including ours, undergoes safety check done by safety department of KAIST. Thus, we believe there are no safety problems with researchers during our project. </little> | ||
+ | </br></br></br> | ||
- | + | <li><span id="sub-title">Public safety</span></li></br> | |
+ | |||
+ | <span id="little"> | ||
+ | Our project mainly deals with E. coli K-12 strain which has been assessed to be non-pathogenic by WHO. Thus, this bacterial strain cannot permanently colonize the colon of healthy humans or animals, not causing any serious diseases. In addition, both our projects need certain conditions to express desired function or metabolism. For example, our project to transform Wood-ljungdahl pathway into E. coli K-12 strain has been done in anaerobic chamber. In other words, once the bacterial strain is kept in anaerobic container or incubator, it will not cause any potential damage to the public and if the container leaks, the condition will turn into aerobic one which will stop the bacterial strain to run desired metabolism. Moreover, another project of ours deals with invertase gene which needs induction to initiate its function, thus we can tell that our projects are completely under our control. That’s why we believe there are no safety problems raised to the public due to our research. </span></br></br></br> | ||
+ | |||
+ | <li><span id="sub-title">Environmental safety? </span></li></br> | ||
+ | |||
+ | <span id="little"> | ||
+ | For environmental safety, every waste generated during experiments is disposed by following policies of KAIST. All solid wastes (lab gloves, pipette tips, petri dish, falcon tubes, culture tubes, EP tubes, lab tissues etc.) are collected in a designated container while liquid wastes such as reagents or culture media are exclusively collected in different container. In case of toxic reagents such as carcinogen, we prepared another container exclusively used for these reagents. In addition, damaging wastes (razor blades, syringe needles, broken parts of flasks etc.) are separately collected and disposed. Disposal of all these wastes are done every Friday by selected company. Hence, our project does not raise any environmental biosafety issues. </span> | ||
+ | </ul> | ||
+ | </br></br></br></br> | ||
+ | |||
+ | <span id="sub-sub-title">2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes, </span></br></br> | ||
+ | |||
+ | <ul> | ||
+ | <span id="little"> | ||
+ | <span id="starter">T</span>here are no BioBrick parts that raise any safety issues in our project. We only deal with BL1 or BL2 organisms and materials which may not cause harm to the researcher, to the public, and to the environment. </span></ul></br></br></br></br> | ||
+ | |||
+ | <span id="sub-sub-title">3. Is there a local biosafety group, committee, or review board at your institution? </span></br></br> | ||
+ | |||
+ | <ul> | ||
+ | |||
+ | <li><span id="sub-title">If yes, what does your local biosafety group think about your project? </span></li></br> | ||
+ | |||
+ | <span id="little"> | ||
+ | As we mentioned above, KAIST has its own biosafety assessment group in its Safety Team under Department of Facility Management. They assessed our laboratory condition as well as our protocols of experiment and disposal periodically and diagnosed that our project has no potential safety issue up to this point. Also, every student of KAIST has to take an online test of Research Safety and Ethics given by this Safety Team and of course all of iGEM team members have passed this. Thus, our school Safety Team certifies our iGEM team members’ knowledge and concern about research safety. </span></br></br></br> | ||
+ | |||
+ | <li><span id="sub-title">If no, which specific biosafety rules or guidelines do you have to consider in your country? </span></li></br> | ||
+ | |||
+ | <span id="little"> | ||
+ | In addition to KAIST Safety Team, there are two organizations which regulate biosafety issues in Korea. One is Korea Centers for Disease Control and Prevention of Korea National Institute of Health and the other is Korean Biological Safety Association (KOBSA). The former is a governmental organization which deals with the issues related to disease which includes pathogenic bacteria used in research. This facility points out specific bacterial strains which is highly pathogenic to the researchers and public. In addition, it provides research protocols that are verified to be biologically safe and performs inspection of the laboratories with potential safety problems. On the other hand, KOBSA, is a nongovernmental organization which is relatively new compared to Korea Centers for Disease Control and Prevention. This organization educates and nurtures biosafety consultants who can assess and give solution to labs which deals with BL2 or organisms of higher level or biosafety issue. Between these two organizations, we found the safety protocols of Korea Centers for Disease Control and Prevention to be relevant to this safety issues. Thus, our research protocols refer to the safety protocols from this governmental organization. </span></ul> | ||
+ | </br></br></br></br> | ||
+ | |||
+ | <span id="sub-sub-title">4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?</span></br></br> | ||
+ | |||
+ | <ul> | ||
+ | <span id="little"> | ||
+ | For future evaluation of safety issues, we propose iGEM committee to ask participants for pictures of their lab life. We found that iGEM committee only ask us to answer their questions in words and in this way some teams may cheat on the questions since there is no requirement for proofs. Thus, we believe asking teams to admit pictures of their laboratory, such as the containers for waste disposal, experimental procedures, and other equipment they use to avoid safety problems. We also suggest requiring safety protocols of each lab and institution, which will further help iGEM judges to evaluate each team’s concerns about safety issues in easier but still objective way. | ||
+ | </span></ul></br></br></br></br> | ||
+ | |||
+ | </div> | ||
+ | |||
+ | |||
+ | </div> | ||
+ | <div id="kaist-footerbox"><img id="footer-img" align="middle" src="https://static.igem.org/mediawiki/2013/e/ef/Footer_background_kaist.png"></img> | ||
+ | </div> | ||
+ | </body> | ||
+ | </html> |
Latest revision as of 08:45, 23 August 2013
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
2013 KAIST Korea
Mail : kaist.igem.2012@gmail.com
Twitter : twitter.com/KAIST_iGEM_2012
Facebook : www.facebook.com/KAISTiGEM2012
Safety
1. Would any of your project ideas raise safety issues in terms of:- Researcher For researcher safety, KAIST iGEM 2012 team follows rules of KAIST biology labs. Every researcher of our team wears latex gloves and lab coats in the lab which are sterilized frequently by spraying 70% ethanol. When treating toxic and volatile reagents, such as TEMED (the reagent used in SDS gel), we use chemical hood. Among several toxic reagents, potential carcinogens are those that are treated most carefully. To minimize the use of carcinogen, we do not use Ethidium Bromide (EtBr) in gel electrophoresis. Rather, we use RedSafeTM nucleic acid staining solution (CHEMBIO) to stain DNA samples when running gel electrophoresis. Since this reagent is said to be non-toxic, non-mutagenic, and non-carcinogenic, we believe using this reagent when making agarose gel would lessen the threat to researchers as well as to the environment. In addition, acrylamide, a component of SDS gel, is known as a potent neurotoxin hence we always wear latex gloves when preparing and running SDS PAGE. Plus, every month, every lab, including ours, undergoes safety check done by safety department of KAIST. Thus, we believe there are no safety problems with researchers during our project.
- Public safety Our project mainly deals with E. coli K-12 strain which has been assessed to be non-pathogenic by WHO. Thus, this bacterial strain cannot permanently colonize the colon of healthy humans or animals, not causing any serious diseases. In addition, both our projects need certain conditions to express desired function or metabolism. For example, our project to transform Wood-ljungdahl pathway into E. coli K-12 strain has been done in anaerobic chamber. In other words, once the bacterial strain is kept in anaerobic container or incubator, it will not cause any potential damage to the public and if the container leaks, the condition will turn into aerobic one which will stop the bacterial strain to run desired metabolism. Moreover, another project of ours deals with invertase gene which needs induction to initiate its function, thus we can tell that our projects are completely under our control. That’s why we believe there are no safety problems raised to the public due to our research.
- Environmental safety? For environmental safety, every waste generated during experiments is disposed by following policies of KAIST. All solid wastes (lab gloves, pipette tips, petri dish, falcon tubes, culture tubes, EP tubes, lab tissues etc.) are collected in a designated container while liquid wastes such as reagents or culture media are exclusively collected in different container. In case of toxic reagents such as carcinogen, we prepared another container exclusively used for these reagents. In addition, damaging wastes (razor blades, syringe needles, broken parts of flasks etc.) are separately collected and disposed. Disposal of all these wastes are done every Friday by selected company. Hence, our project does not raise any environmental biosafety issues.
-
There are no BioBrick parts that raise any safety issues in our project. We only deal with BL1 or BL2 organisms and materials which may not cause harm to the researcher, to the public, and to the environment.
- If yes, what does your local biosafety group think about your project? As we mentioned above, KAIST has its own biosafety assessment group in its Safety Team under Department of Facility Management. They assessed our laboratory condition as well as our protocols of experiment and disposal periodically and diagnosed that our project has no potential safety issue up to this point. Also, every student of KAIST has to take an online test of Research Safety and Ethics given by this Safety Team and of course all of iGEM team members have passed this. Thus, our school Safety Team certifies our iGEM team members’ knowledge and concern about research safety.
- If no, which specific biosafety rules or guidelines do you have to consider in your country? In addition to KAIST Safety Team, there are two organizations which regulate biosafety issues in Korea. One is Korea Centers for Disease Control and Prevention of Korea National Institute of Health and the other is Korean Biological Safety Association (KOBSA). The former is a governmental organization which deals with the issues related to disease which includes pathogenic bacteria used in research. This facility points out specific bacterial strains which is highly pathogenic to the researchers and public. In addition, it provides research protocols that are verified to be biologically safe and performs inspection of the laboratories with potential safety problems. On the other hand, KOBSA, is a nongovernmental organization which is relatively new compared to Korea Centers for Disease Control and Prevention. This organization educates and nurtures biosafety consultants who can assess and give solution to labs which deals with BL2 or organisms of higher level or biosafety issue. Between these two organizations, we found the safety protocols of Korea Centers for Disease Control and Prevention to be relevant to this safety issues. Thus, our research protocols refer to the safety protocols from this governmental organization.
-
For future evaluation of safety issues, we propose iGEM committee to ask participants for pictures of their lab life. We found that iGEM committee only ask us to answer their questions in words and in this way some teams may cheat on the questions since there is no requirement for proofs. Thus, we believe asking teams to admit pictures of their laboratory, such as the containers for waste disposal, experimental procedures, and other equipment they use to avoid safety problems. We also suggest requiring safety protocols of each lab and institution, which will further help iGEM judges to evaluate each team’s concerns about safety issues in easier but still objective way.